Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001615774-17-001275
Filing Date
2017-03-28
Accepted
2017-03-28 15:06:09
Documents
76
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K s105634_10k.htm 10-K 1073192
2 EXHIBIT 10.24 s105634_ex10-24.htm EX-10.24 3698
3 EXHIBIT 23.1 s105634_ex23-1.htm EX-23.1 2172
4 EXHIBIT 31.1 s105634_ex31-1.htm EX-31.1 9903
5 EXHIBIT 31.2 s105634_ex31-2.htm EX-31.2 9853
6 EXHIBIT 32.1 s105634_ex32-1.htm EX-32.1 4719
7 EXHIBIT 32.2 s105634_ex32-2.htm EX-32.2 4695
  Complete submission text file 0001615774-17-001275.txt   5183479

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE bthi-20161231.xml EX-101.INS 886858
9 XBRL SCHEMA FILE bthi-20161231.xsd EX-101.SCH 49265
10 XBRL CALCULATION FILE bthi-20161231_cal.xml EX-101.CAL 66354
11 XBRL DEFINITION FILE bthi-20161231_def.xml EX-101.DEF 215744
12 XBRL LABEL FILE bthi-20161231_lab.xml EX-101.LAB 424179
13 XBRL PRESENTATION FILE bthi-20161231_pre.xml EX-101.PRE 330013
Mailing Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843
Business Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843 (603) 935-9799
Boston Therapeutics, Inc. (Filer) CIK: 0001473579 (see all company filings)

EIN.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54586 | Film No.: 17718684
SIC: 2834 Pharmaceutical Preparations